Drug
Bavdegalutamide
Bavdegalutamide: highest development phase Phase 1, developed by Arvinas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arvinas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bavdegalutamide NCT05177042 | Phase 1 | Prostate Cancer Metastatic |
Latest
No recent events.
Follow Bavdegalutamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.